Extended-Release Medication

Why Choose an Extended-Release Medication Treatment?

Less Daily Pressure

Built for Real Life

Increased Privacy

Improved Safety

The Science of the “Steady State”

Extended-Release Treatment Options

Sublocade is a monthly extended-release buprenorphine medication for patients who want consistent support without taking medication every day. 

Brixadi is an extended-release buprenorphine medication that offers both weekly and monthly dosing. 

 

This makes it possible to begin with more frequent support and shift to longer intervals as treatment stability improves. 

 

Its smaller injection volume and multiple injection site options make it a flexible choice for many patients. 

Vivitrol is a once-monthly, non-opioid extended-release medication that blocks receptors instead of activating them. 

 

It is FDA-approved for both opioid use disorder and alcohol use disorder, making it an option for patients seeking a non-narcotic medication path

Is an Extended-Release Medication Option Right for You?

A Simpler Way to Stay Consistent, With Mahajan Therapeutics

Recovery already calls for time, effort, and focus. Your treatment plan should help simplify that work. 

 

Extended-release MAT can lessen daily decision-making, lower stress, and provide consistent support in the background so patients can concentrate on moving forward. 

 

If you want to explore an option beyond daily dosing, Mahajan Therapeutics can help you determine whether extended-release medication belongs in your treatment plan. 

 

Speak with our medical team to learn which extended-release medication option matches your goals. We can help you build a plan that includes medication, counseling, and ongoing support.